Amneal Pharmaceuticals (AMRX) EBT (QoQ) (2017 - 2026)
Amneal Pharmaceuticals (AMRX) EBT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.71 Bn | 5.58 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.46% |
| Mar 31, 2026 | 45.15% |
| Dec 31, 2025 | 1,157.53% |
| Sep 30, 2025 | -110.10% |
| Jun 30, 2025 | 37.95% |
| Mar 31, 2025 | 344.70% |
| Dec 31, 2024 | -199.33% |
| Sep 30, 2024 | -24.42% |
| Jun 30, 2024 | 127.02% |
| Mar 31, 2024 | 9.51% |
| Dec 31, 2023 | -463.55% |
| Sep 30, 2023 | -22.60% |
| Jun 30, 2023 | 414.66% |
| Mar 31, 2023 | -23.14% |
| Dec 31, 2022 | -451.15% |
| Sep 30, 2022 | 100.94% |
| Jun 30, 2022 | -2,245.84% |
| Mar 31, 2022 | 39.21% |
| Dec 31, 2021 | -698.78% |
| Sep 30, 2021 | -105.87% |